Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010.
Sanchez GV, Master RN, Karlowsky JA, Bordon JM.
Antimicrob Agents Chemother. 2012 Apr;56(4):2181-3. Epub 2012 Jan 17.
Related citations
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J.
Clin Infect Dis. 2012 Mar 1;54(5):621-9. Epub 2012 Jan 12.
Antibiotic treatment against methicillin-resistant Staphylococcus aureus hospital- and ventilator-acquired pneumonia: a step forward but the battle continues.
Torres A.
Clin Infect Dis. 2012 Mar 1;54(5):630-2. Epub 2012 Jan 12. No abstract available.
The importance of source identification in septic patients.
Mergulhão P, Paiva JA.
Crit Care Med. 2011 Dec;39(12):2786-7; author reply 2787. No abstract available.
Long-term clinical and economic benefits associated with the management of a nosocomial outbreak resulting from extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Piednoir E, Thibon P, Borderan GC, Godde F, Borgey F, Le Coutour X, Parienti JJ.
Crit Care Med. 2011 Dec;39(12):2672-7.
Silver resistance: an alarming public health concern?
Jakobsen L, Andersen AS, Friis-Møller A, Jørgensen B, Krogfelt KA, Frimodt-Møller N.
Int J Antimicrob Agents. 2011 Nov;38(5):454-5. Epub 2011 Sep 3. No abstract available.
Pseudomonas aeruginosa and carbapenems: the urgent need to harmonise disagreeing breakpoints.
Gómez-Garcés JL, López-Fabal F, Burillo A, Gil Y.
Int J Antimicrob Agents. 2011 Nov;38(5):452-3. Epub 2011 Sep 1. No abstract available.
Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.
Wang H, Chen M, Xu Y, Sun H, Yang Q, Hu Y, Cao B, Chu Y, Liu Y, Zhang R, Yu Y, Sun Z, Zhuo C, Ni Y, Hu B, Tan TY, Hsueh PR, Wang JH, Ko WC, Chen YH, Wahjono H.
Int J Antimicrob Agents. 2011 Nov;38(5):376-83. Epub 2011 Aug 30.
Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa.
Ruiz-Martínez L, López-Jiménez L, Fusté E, Vinuesa T, Martínez JP, Viñas M.
Int J Antimicrob Agents. 2011 Nov;38(5):398-402. Epub 2011 Aug 27.
In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa.
Mitsugui CS, Tognim MC, Cardoso CL, Carrara-Marroni FE, Botelho Garcia L.
Int J Antimicrob Agents. 2011 Nov;38(5):447-50. Epub 2011 Aug 26.
Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
Ben RJ, Yang MC, Hsueh JC, Shiang JC, Chien ST.
Int J Antimicrob Agents. 2011 Nov;38(5):403-8. Epub 2011 Aug 26.
Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.
Alcazar-Fuoli L, Cuesta I, Rodriguez-Tudela JL, Cuenca-Estrella M, Sanglard D, Mellado E.
Int J Antimicrob Agents. 2011 Nov;38(5):426-34. Epub 2011 Aug 25.
Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
Patel D, Husain M, Vidaillac C, Steed ME, Rybak MJ, Seo SM, Kaatz GW.
Int J Antimicrob Agents. 2011 Nov;38(5):442-6. Epub 2011 Aug 12.
Molecular characterisation of multidrug-resistant Salmonella enterica serotype Infantis from humans, animals and the environment in Italy.
Dionisi AM, Lucarelli C, Benedetti I, Owczarek S, Luzzi I.
Int J Antimicrob Agents. 2011 Nov;38(5):384-9. Epub 2011 Aug 6.
In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms.
Tang HJ, Chen CC, Cheng KC, Toh HS, Su BA, Chiang SR, Ko WC, Chuang YC.
J Antimicrob Chemother. 2012 Apr;67(4):944-50. Epub 2012 Jan 18.
Clonal diversity and biofilm-forming ability of methicillin-resistant Staphylococcus pseudintermedius.
Osland AM, Vestby LK, Fanuelsen H, Slettemeås JS, Sunde M.
J Antimicrob Chemother. 2012 Apr;67(4):841-8. Epub 2012 Jan 18.
Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study.
Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM.
J Antimicrob Chemother. 2012 Apr;67(4):1010-5. Epub 2012 Jan 11.
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy.
Vicenti I, Rosi A, Saladini F, Meini G, Pippi F, Rossetti B, Sidella L, Di Giambenedetto S, Almi P, De Luca A, Caudai C, Zazzi M.
J Antimicrob Chemother. 2012 Apr;67(4):984-7. Epub 2012 Jan 18.
The carbon source influences the efflux pump-mediated antimicrobial resistance in clinically important Gram-negative bacteria.
Villagra NA, Fuentes JA, Jofré MR, Hidalgo AA, García P, Mora GC.
J Antimicrob Chemother. 2012 Apr;67(4):921-7. Epub 2012 Jan 17.
Phenotypic screening of carbapenemases and associated β-lactamases in carbapenem-resistant Enterobacteriaceae.
Birgy A, Bidet P, Genel N, Doit C, Decré D, Arlet G, Bingen E.
J Clin Microbiol. 2012 Apr;50(4):1295-302. Epub 2012 Jan 18.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on